A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer treatment reviews"
DOI: 10.1016/j.ctrv.2021.102300
Abstract: BACKGROUND A high number of combinations of PD-1/PD-L1 inhibitors with other anti-cancer therapies are in clinical development. The usefulness of phase II trials in evaluating their efficacy and safety is unclear. MATERIALS AND METHODS We… read more here.
Keywords: phase; exploring anti; review phase; systematic review ... See more keywords